[The long-term chemical stability of injectable drugs reconstituted in Hospital Pharmacy].

Journal de pharmacie de Belgique Pub Date : 2015-09-01
J D Hecq, M Godet, J Jamart, B Bihin, L Galanti
{"title":"[The long-term chemical stability of injectable drugs reconstituted in Hospital Pharmacy].","authors":"J D Hecq,&nbsp;M Godet,&nbsp;J Jamart,&nbsp;B Bihin,&nbsp;L Galanti","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Other injectable preparations than parenteral nutrition admixture and injectable cytotoxic drugs could be prepared by Centralised IntraVenous Admixture Service (CIVAS) if the Long-term stability of the drugs is known. However, this information is not always available.</p><p><strong>Purpose: </strong>To develop a program of chemical drug stability analysis in collaboration between Hospital Pharmacy, Medical Laboratory and Scientific Support Unit to determine the long-term stability of largely used injectable anti-infectious and non-anti-infectious drugs.</p><p><strong>Material and methods: </strong>After a setup of the High Performance Liquid Chromatography (HPLCI method, 28 drugs were reconstituted in laminar air flow hood, 17 of them stored directly at 5 +/- 3 degrees C and 19 stored in the freezer at -20 degrees C, thawed by microwave following a standardised procedure and stored at 5 +/- 3 degrees C before use. Concentration stability was evaluated by regression analysis.</p><p><strong>Results: </strong>For each drug, long-term stability has varied from 11 days to 180 days. The freeze-thaw treatment by microwave may enhance the stability (from 30 to 120 days) and allow batch-scale production of intravenous drugs, less expensive in term of manpower and sterile device than a drug reconstitution at the ward. The results were published by 55 posters in international congress and by 36 publications in national and international pharmaceutical journals.</p><p><strong>Conclusions: </strong>Our findings contribute to enhance the scale of drugs that may be take on by a CIVAS.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":" 3","pages":"36-44"},"PeriodicalIF":0.0000,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal de pharmacie de Belgique","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Other injectable preparations than parenteral nutrition admixture and injectable cytotoxic drugs could be prepared by Centralised IntraVenous Admixture Service (CIVAS) if the Long-term stability of the drugs is known. However, this information is not always available.

Purpose: To develop a program of chemical drug stability analysis in collaboration between Hospital Pharmacy, Medical Laboratory and Scientific Support Unit to determine the long-term stability of largely used injectable anti-infectious and non-anti-infectious drugs.

Material and methods: After a setup of the High Performance Liquid Chromatography (HPLCI method, 28 drugs were reconstituted in laminar air flow hood, 17 of them stored directly at 5 +/- 3 degrees C and 19 stored in the freezer at -20 degrees C, thawed by microwave following a standardised procedure and stored at 5 +/- 3 degrees C before use. Concentration stability was evaluated by regression analysis.

Results: For each drug, long-term stability has varied from 11 days to 180 days. The freeze-thaw treatment by microwave may enhance the stability (from 30 to 120 days) and allow batch-scale production of intravenous drugs, less expensive in term of manpower and sterile device than a drug reconstitution at the ward. The results were published by 55 posters in international congress and by 36 publications in national and international pharmaceutical journals.

Conclusions: Our findings contribute to enhance the scale of drugs that may be take on by a CIVAS.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
医院药房重组注射用药物的长期化学稳定性
背景:除肠外营养合剂和注射细胞毒性药物外,如果已知药物的长期稳定性,可以通过集中静脉制剂中心(CIVAS)制备其他注射制剂。然而,这些信息并不总是可用的。目的:建立医院药房、医学实验室和科学支持单位合作的化学药物稳定性分析方案,以确定常用的注射用抗感染和非抗感染药物的长期稳定性。材料和方法:建立高效液相色谱(HPLCI)方法后,28种药物在层流通风罩中重组,其中17种药物在5 +/- 3℃直接保存,19种药物在-20℃冷冻,按标准化程序微波解冻,5 +/- 3℃保存后使用。通过回归分析评价其浓度稳定性。结果:每种药物的长期稳定性从11天到180天不等。微波冻融处理可以提高稳定性(从30天到120天),并允许批量生产静脉注射药物,在人力和无菌设备方面比在病房进行药物重组更便宜。研究结果在国际大会上发表了55篇论文,在国内和国际药学期刊上发表了36篇论文。结论:我们的发现有助于提高CIVAS可能承担的药物规模。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Hepatitis C]. [Essential oils: good advice by the pharmacist is necessary]. [Practical guidelines to ensure the quality of compounded preparations in community pharmacies]. [The social sciences at the Faculty of Pharmacy: and innovative course of community health at the University of Montreal]. [Pharmaceutical care for pediatric hemato-oncology and stem cell transplantation patients. Inventory of experiences and needs].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1